Becton Dickinson & Co

MEX : BDX
USA·Healthcare·Medical Devices & Instruments
MX$2,683.83
+0.00 (+0.00%)latest daily quote
Market Cap
MX$763.46B
Enterprise Value
MX$1.04T
P/E (TTM)
54.81
P/B
2.03
Net Cash / (Debt)
−MX$279.68B
52-Week Range
—
5-Year Range
—
Avg Volume (3M)
2.73K

Becton Dickinson (BD) makes and sells medical devices and equipment to hospitals, clinics, and pharmaceutical companies worldwide.

Its four main businesses are: - Medical essentials (35%): everyday clinical supplies like syringes, catheters, and infection prevention products sold to hospitals - Connected care (24%): infusion pumps (Alaris), medication dispensing cabinets (Pyxis), and pharmacy automation systems used by hospital pharmacies and nursing staff - Biopharma systems (13%): prefillable syringes and autoinjectors sold to drug manufacturers for packaging injectable medications - Interventional (29%): devices for surgery, peripheral vascular procedures, and urology

Revenue is largely recurring — hospitals continuously reorder consumables and disposables. Over 60% of sales come from the U.S.

Employees72,000IPOMay 4, 2018SIC3841HQ1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
to

Financials (MXN)

Profitability

Metric
Current
Margins
Gross Margin
46.9%
Operating Margin
14.4%
EBITDA Margin
21.5%
Net Margin
4.1%
OCF Margin
14.1%
FCF Margin
10.8%
Returns on Capital
ROE
3.8%
ROA
1.8%
ROIC
6.2%
ROCE
5.7%
ROC (Greenblatt)
30.7%
3Y ROIIC
41.4%
Consistency
Years Profitable / 10Y
10

Valuation

Metric
Current
Earnings Multiples
P/E (TTM)
54.81
Forward P/E
12.00
P/E ex-NRI
15.60
Shiller P/E (CAPE)
35.88
Cash Flow Multiples
P/FCF
20.56
P/OCF
15.82
P/Owner Earnings
25.78
FCF Yield
5.03%
Enterprise Value Multiples
EV / EBIT
25.86
EV / Forward EBIT
29.24
EV / EBITDA
13.19
EV / Forward EBITDA
15.14
EV / Revenue
2.83
EV / Forward Revenue
3.29
Asset / Sales
P/S
2.22
P/B
2.03
P/Tangible Book
—
Growth-Adjusted
PEG
2.03

Capital Returns

Metric
Current
Dividends
Dividend Yield (TTM)
2.81%
Forward Dividend Yield
2.73%
3Y Dividend Growth
6.1%
Payout Ratio
0.36
5Y Yield on Cost
3.66%
Buybacks & Dilution
3Y Buyback Ratio
−0.20%
Combined
Shareholder Yield
9.17%

Balance Sheet

Metric
Current
Leverage
Debt / Equity
0.69
Gross Debt / EBITDA
3.36
Cash / Debt
0.04
Equity / Assets
0.48
Coverage
Interest Coverage
5.68
Short-Term Liquidity
Current Ratio
0.87
Quick Ratio
0.51
Cash Ratio
0.08
Composite Scores
Piotroski F-Score
7
Altman Z-Score
2.21

5-Step DuPont Analysis

ROE %
3.77%
Net Margin %
4.13%
Operating Margin %
14.40%
Operating Income
MX$60.36B
÷
Revenue
MX$419.28B
×
Tax Burden
0.4857
Net Income
MX$17.33B
÷
Pretax Income
MX$35.67B
×
Interest Burden
0.5910
Pretax Income
MX$35.67B
÷
Operating Income
MX$60.36B
×
Asset Turnover
0.43
Revenue
MX$419.28B
÷
Average Total Assets
MX$974.22B
Begin Total Assets
MX$1.07T
End Total Assets
MX$881.33B
×
Equity Multiplier
2.12
Avg Total Assets
MX$974.22B
÷
Avg Stockholders Equity
MX$459.64B
Begin Equity
MX$495.11B
End Equity
MX$424.17B